Tag: Lin Ching Yang
Firms act on Kelun-Biotech’s HKD1.9bn H-share placement
Zhong Lun, S&C, Kirkland & Ellis advised on Kelun-Biotech’s HKEX H-share placement raising HKD1.94b (USD250m)
Sullivan & Cromwell steers Saudi Arabian joint venture
Sullivan & Cromwell advised Foxconn Interconnect Technology on a USD100 million joint venture with Saudi Arabia’s Saleh Suleiman Alrajhi & Sons
Fangda, Sullivan & Cromwell act on XPeng buy of Didi’s EV unit
Fangda Partners and Sullivan & Cromwell have advised Chinese electric vehicle maker XPeng on its HKD5.84 billion (USD744 million) acquisition of Didi Global
Taiwanese company to buy ABB’s power conversion arm
Sullivan & Cromwell advised Taiwanese switching power supply manufacturer AcBel Polytech and Millbank represented Swedish-Swiss multinational ABB in the former’s acquisition of the latter’s US-based electricity conversion division for USD505 million
AIM Vaccine taps S&C and Jingtian on HKD156m listing on HKEX
China’s biggest privately owned vaccine group AIM Vaccine enlisted legal advice from Sullivan & Cromwell (S&C) and Jingtian & Gongcheng for its debut on the HKEX
